The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer

Published:2018-10-24 Issue:17 Volume:19 Page:1969-1976
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Rossi Giovanni¹,Alama Angela¹,Genova Carlo²^ORCID,Rijavec Erika¹,Tagliamento Marco¹^ORCID,Biello Federica¹,Coco Simona¹,Dal Bello Maria Giovanna¹,Boccardo Simona¹,Grossi Francesco²

Affiliation:

1. Lung Cancer Unit, Ospedale Policlinico San Martino, Genoa, Italy

2. Medical Oncology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1536746

Reference53 articles.

1. Cancer statistics, 2018

2. Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance

3. Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition

4. Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer

5. Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17

2. Pemetrexed ameliorates Con A-induced hepatic injury by restricting M1 macrophage activation;International Immunopharmacology;2023-12

3. Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review;Critical Reviews in Oncology/Hematology;2023-08

4. Metabolomics in oncology;Cancer Reports;2023-02-21

5. GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate;Journal of Innate Immunity;2022-11-14